Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The European market for EP mapping and ablation devices will experience moderate growth through 2027, largely as a result of increasing ablation volumes and the use of premium-priced devices in AF treatments.
This Medtech 360 Report provides key market metrics for the EP mapping and ablation device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
Already a Client? Log in to access this report.
Erik J. Bracciodieta is a senior analyst within the Cardiovascular Medtech Insights team, specializing in cardiac rhythm management and structural heart closure device markets, as well as medical device pricing and regulations in Japan. Erik holds a Master's degree in Biotechnology from the University of Toronto. Follow Erik on Twitter: @ErikB_DRG.